People · Operator
Named in public records as an officer, director or promoter · active 2013–2025 · Other Health Care, Investment Vehicle, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Wugen, Inc. | — | Other Health Care | Series D+ | $245.2M | $870.3M | 2025 |
| Enumera Molecular, Inc. | — | Other Health Care | Series B | $18.7M | $236.5M | 2022 |
| Maximalto Ventures I LLC | — | Investment Vehicle | Series A | $8.4M | $92.8M | 2021 |
| Concierge Pediatrics Holdings, LLC | — | Other Health Care | Seed | $2.1M | $4.3M | 2023 |
| Carmenta Bioscience, Inc. | — | Biotechnology | Pre-Seed | $586K | $32.3M | 2013 |
Matthew Cooper at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Matthew Cooper on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian Levy | 1 | 8 |
| Niall O'Donnell | 1 | 7 |
| Drew Dennison | 1 | 7 |
| Bosun Hau | 1 | 6 |
| Peter Kiener | 1 | 4 |
| Kevin Li | 1 | 4 |
| Bali Muralidhar | 1 | 3 |
| John P McKearn | 1 | 2 |
| Keith Vendola | 1 | 2 |
| Kumar Srinivasan | 1 | 2 |
| Matthew P Cooper | 1 | 1 |
| Kevin P Li | 1 | 1 |
| Drew P Dennison | 1 | 1 |
| Jeffrey Schor | 1 | 1 |
| Bryan Calka | 1 | 1 |
| Jonathan Jassey | 1 | 1 |
| Ross Mallor | 1 | 1 |
| Marc Honigfeld | 1 | 1 |
| Atul Butte | 1 | 1 |
| Bruce Ling | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.